Ambipar Emergency Response AMBIQ
0.00
0.00
NaN
as of 23 Sep
- Market cap
- $29.9M
- P/E
- 0.0×
Follow AMBIQ
Growth Flags
show if company had growth for consecutive years
| Dec '24 | Sep '24 | Jun '24 | Mar '24 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | — | 0.00 | |
P/FCF ratio |
— | — | — | 7.69 | |
P/Operating CF |
— | — | — | 11.33 | |
P/B ratio |
— | — | — | 1.02 | |
Price to Tangible BV |
— | — | — | 0.00 | |
EV/Sales |
— | — | — | 0.00 | |
EV/EBITDA |
— | — | — | 0.00 | |
EV/Operating CF |
— | — | — | 5.31 | |
EV/FCF |
— | — | — | 16.19 | |
Quick Ratio |
— | 1.88 | 2.09 | 1.94 | |
Current Ratio |
— | 2.07 | 2.29 | 2.10 | |
Net Debt/EBITDA |
— | 0.00 | 0.00 | 9.00 | |
Debt/Assets |
0.00% | 47.29% | 48.12% | 47.43% | |
Debt/Equity |
— | 1.45 | 1.43 | 1.51 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
— | 0.00 | 0.00 | 18.43 | |
Capex/Depreciation |
— | (0.18) | (0.08) | (0.23) | |
Interest Coverage |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 1.27% | |
Intangible Assets out of Total Assets |
0.00 | 0.39 | 0.42 | 0.43 | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Graham Net Nets |
— | — | — | (1.09) | |
Graham Number |
— | — | — | 0.00 | |
Earnings Yield |
— | — | — | (12.40%) | |
Free Cash Flow Yield |
— | — | — | 13.00% | |
Revenue per Share |
— | — | — | 2.47 | |
Operating CF per Share |
— | 0.00 | 0.00 | 0.46 | |
Capex per Share |
— | 0.00 | 0.00 | (0.05) | |
Free Cash Flow per Share |
— | 0.00 | 0.00 | 0.41 | |
Cash per Share |
— | 0.00 | 0.00 | 1.94 | |
Shareholders Equity per Share |
— | 0.00 | 0.00 | 5.11 | |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | |
Book value per Share |
— | 0.00 | 0.00 | 5.11 | |
Free Cash Flow |
— | 48.73 | 5.12 | 22.76 | |
Working Capital |
— | 154.61 | 179.04 | 158.29 | |
Capital Expenditures |
— | (7.33) | (1.18) | (2.73) | |
Net Current Asset Value |
— | (333.64) | (313.10) | (314.18) | |
EV/EBIT |
— | — | — | 6.75 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.02 | |
Net Profit Margin |
— | — | — | 1.01% | |
Price to Operating Income |
— | — | — | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 178.51 | 167.27 | — | |
Average Payables |
— | 28.72 | 29.48 | 17.38 | |
Average Inventory |
— | 9.37 | 7.48 | — | |
Average Assets |
413.50 | 866.02 | 808.15 | 479.11 | |
Average Common Equity |
— | 272.15 | 203.73 | 135.07 |
Columns are period end dates